Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Rasmussen's syndrome, an autoimmune disease].

A Carrillo Herranz1, I Sánchez Pérez, J M Aparicio Meix

  • 1Servicios de Pediatría. Hospital Ramón y Cajal. Madrid. España. acarrillo.hrx@salud.madrid.org

Anales De Pediatria (Barcelona, Spain : 2003)
|July 29, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

P53 pathway is a major determinant in the radiosensitizing effect of Palbociclib: Implication in cancer therapy.

Cancer letters·2019
Same author

[The retina, a window to the cardiovascular baggage].

Semergen·2015
Same author

Collagenous colitis and collagenous gastritis in a 9 year old girl: a case report and review of the literature.

Acta gastro-enterologica Belgica·2011
Same author

Allergy assessment in children with eosinophilic esophagitis.

Journal of investigational allergology & clinical immunology·2011
Same author

[Acanthosis nigricans in 43 year old woman].

Revista clinica espanola·2009
Same author

Prevalence of allergy and anaphylactic symptoms in 210 adult and pediatric patients with mastocytosis in Spain: a study of the Spanish network on mastocytosis (REMA).

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2007
Same journal

[Annual report of Anales de Pediatría editors].

Anales de pediatria (Barcelona, Spain : 2003)·2024
Same journal

[COVID-19: Critical appraisal of the evidence].

Anales de pediatria (Barcelona, Spain : 2003)·2024
Same journal

[Usefulness of chest ultrasound in a neonatal infection due to SARS-CoV-2].

Anales de pediatria (Barcelona, Spain : 2003)·2024
Same journal

[Cutaneous manifestations in the current pandemic of coronavirus infection disease (COVID 2019)].

Anales de pediatria (Barcelona, Spain : 2003)·2024
Same journal

[Breastfeeding app updates and recommendations].

Anales de pediatria (Barcelona, Spain : 2003)·2024
Same journal

[The impact of the pandemic on vaccination coverage in Spain: a challenge for pediatrics and public health].

Anales de pediatria (Barcelona, Spain : 2003)·2024
See all related articles

Rasmussen's syndrome, an autoimmune brain disorder, was treated with immunoglobulins and steroids in a young patient. This therapy resolved anti-GAD antibodies and epilepsy symptoms, offering a new treatment avenue.

Area of Science:

  • Neurology
  • Immunology
  • Neuroimmunology

Background:

  • Rasmussen's syndrome is a chronic, progressive brain inflammation causing severe neurological deficits.
  • Conventional treatments like hemispherectomy are invasive; emerging research links it to autoimmune phenomena, specifically anti-glutamic acid decarboxylase (anti-GAD) antibodies.

Observation:

  • A pediatric patient presented with early-stage Rasmussen's syndrome, exhibiting therapy-resistant epilepsy.
  • The patient tested positive for anti-GAD antibodies, indicating an autoimmune basis for the condition.

Findings:

  • Treatment with immunoglobulins and steroids led to the resolution of anti-GAD antibodies.
  • Following treatment, the patient became asymptomatic and remained so for ten months.

Related Experiment Videos

Implications:

  • This case suggests that immunosuppressive therapies, including immunoglobulins and steroids, can be effective for Rasmussen's syndrome associated with anti-GAD antibodies.
  • The findings support a shift towards immunomodulatory treatments for specific autoimmune epilepsy subtypes, potentially avoiding more invasive surgical interventions.